These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24290253)

  • 1. [IV Consensus Meeting of the Spanish Society of Liver Transplantation 2012. Exceptions to model for end-stage liver disease in prioritizing liver transplantation].
    Lladó L; Bustamante J;
    Gastroenterol Hepatol; 2014 Feb; 37(2):83-91. PubMed ID: 24290253
    [No Abstract]   [Full Text] [Related]  

  • 2. End-stage liver disease. Determining when transplant referral is necessary.
    Rosenthal L
    Adv Nurse Pract; 2006 Feb; 14(2):46-8. PubMed ID: 16471308
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined liver-kidney and kidney after liver transplantation: indications and experiences from a nephrological perspective at a single center].
    Seckinger J; Tönshoff B; Stremmel W; Zeier M; Schmidt J
    Dtsch Med Wochenschr; 2010 Oct; 135(40):1973-8. PubMed ID: 20922639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model for end-stage liver disease (MELD) exception for familial amyloidotic polyneuropathy.
    Pomfret E; Gish RG; Brandhagen D
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S100-1. PubMed ID: 17123281
    [No Abstract]   [Full Text] [Related]  

  • 5. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for end-stage liver disease (MELD) exception for primary hyperoxaluria.
    Horslen S; Gish RG; McDonald R
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S117-8. PubMed ID: 17123291
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute on chronic liver failure].
    Escorsell Mañosa A; Mas Ordeig A
    Gastroenterol Hepatol; 2010 Feb; 33(2):126-34. PubMed ID: 20005602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculation and comparison of the model for end-stage liver disease (MELD) score in patients accepted for liver transplantation in 1999 and 2004.
    Flodén A; Castedal M; Friman S; Olausson M; Backman L
    Transplant Proc; 2007 Mar; 39(2):385-6. PubMed ID: 17362737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of waitlisted patients for liver transplantation at a liver transplantation unit in the city of Ribeirão Preto, São Paulo, Brazil, especially considering Child and Model for End Stage Liver Disease (MELD) scores.
    Teixeira AC; Souza FF; Sankarankutty AK; Martinelli AL; Castro E Silva O
    Transplant Proc; 2007 Mar; 39(2):387-9. PubMed ID: 17362738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Consensus document of the Spanish Society of Liver Transplantation. Waiting lists, liver transplantation and quality indicators].
    Sociedad Española de Trasplante Hepático (SETH)
    Gastroenterol Hepatol; 2009 Dec; 32(10):702-16. PubMed ID: 19732993
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined liver-kidney transplantation: indications and results].
    Ferhi K; Lakehal M; Avakian R; Bensallah K; Boudjema K; Patard JJ; Guille F
    Prog Urol; 2008 Apr; 18(4):245-50. PubMed ID: 18501305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [General considerations, indications and contraindications for liver transplantation in Chile: a multicenter consensus development document].
    Hepp J; Zapata R; Buckel E; Martínez J; Uribe M; Díaz JC; Ferrario M; Sanhueza E; Pérez RM; Hunter B; Ríos G; Humeres R; Poniachik J; Oksenberg D; Arrese M
    Rev Med Chil; 2008 Jun; 136(6):793-804. PubMed ID: 18769839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver transplantation--an update].
    Herzer K; Paul A; Gerken G
    Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1471-7. PubMed ID: 23821451
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined heart and liver transplantation: State of knowledge and outlooks.
    Lebray P; Varnous S
    Clin Res Hepatol Gastroenterol; 2019 Apr; 43(2):123-130. PubMed ID: 30635235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MELD exceptions and new predictive score of death on long waiting lists for liver transplantation.
    Iacob S; Gheorghe L; Iacob R; Gheorghe C; Hrehoreţ D; Popescu I
    Chirurgia (Bucur); 2009; 104(3):267-73. PubMed ID: 19601457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heart in liver transplantation.
    Ripoll C; Yotti R; Bermejo J; Bañares R
    J Hepatol; 2011 Apr; 54(4):810-22. PubMed ID: 21145840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pretransplant renal failure: when is listing for kidney-liver indicated?
    Davis CL
    Liver Transpl; 2005 Nov; (11 Suppl 2):S35-44. PubMed ID: 16237696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation--patient selection and timing.
    McCormick A; Sultan J
    Med J Malaysia; 2005 Jul; 60 Suppl B():83-7. PubMed ID: 16108182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined liver and kidney transplantation in Guangzhou, China.
    Zhu XF; He XS; Chen GH; Chen LZ; Wang CX; Huang JF
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):585-9. PubMed ID: 18086622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.